INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB (IFTBF) Stock Price, Quote, News & History

IFTBFOTCGM
$6.18
At close: May 20, 5:00 PM EST
Loading...

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 500.00
Day Range
- - -
52 Wk Range
4.78 - 6.18
Market Cap
-
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
999.99

Recent Infant Bacterial Therapeutics AB News

No news found

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-56.78M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
0
Free Cash Flow (TTM)
-56.78M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-56.78M

Valuation Metrics

Enterprise Value
$64.90M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
9.54
Earnings Yield % (TTM)
-9.06%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.65

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$131.93M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 500.00
Day Range
- - -
52 Wk Range
4.78 - 6.18
Market Cap
-
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
999.99

About

Sector
Health Care
Industry
Pharmaceuticals
Infant Bacterial Therapeutics AB is a pharmaceutical company. Its purpose is to develop and commercialize drugs for diseases affecting premature babies. Its focus is on the drug candidate IBP-9414, whose development program is designed to show a redu...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB (IFTBF) stock?

A

You can purchase shares of INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB (OTCGM:IFTBF) through any online brokerage.

View our list of the best stock brokerages

Q

Who are INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB (IFTBF) competitors?

A

There are no as such competitors for INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB.

Q

What is the forecast, or price target, for INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB (IFTBF) stock?

A

There is no analysis for INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB to provide a consensus price target.

Q

What is the current price for INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB (IFTBF)?

A

The stock price for INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB (OTCGM: IFTBF) is $6.18 last updated February 19, 2026 at 2:24 PM EST.

Q

Does INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB (IFTBF) pay a dividend?

A

There are no upcoming dividends for INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB.

Q

When is INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB (OTCGM:IFTBF) reporting earnings?

A

INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB does not have any upcoming earnings scheduled.

Q

Is INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB (IFTBF) going to split?

A

There is no upcoming split for INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB.

Q

What sector and industry does INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB (IFTBF) operate in?

A

INFANT BACTERIAL AK B ORD by Infant Bacterial Therapeutics AB is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCGM.